PDA Israel

Background PDA was founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry. Today, coordinated through its headquarters and manufacturing training facility in Bethesda, Maryland, and Europe office in Berlin, Germany, PDA volunteers worldwide carry out its mission of promoting the exchange of rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production. PDA is the recognized authoritative voice and leading technical organization in the field of parenteral science and technology. Through the development of Technical Reports and other documents and responses to regulatory initiatives, PDA and its members influence the future course of pharmaceutical products technology. With more than 10,500 individual members worldwide, PDA draws its strength from the technical expertise of its membership. Conferences, meetings, and courses bring together pharmaceutical manufacturers, suppliers, users, academics, and regulatory officials to discuss and boost issues of mutual interest. These exchanges of technical knowledge, expertise, and best practices assist the advancement of pharmaceutical science and technology in the interest of public health. The PDA Israel Chapter The PDA Israel Chapter was founded in 1997 and is made up of the Executive committee, including the president, president-elect, treasurer and liaison with international PDA, and the Steering committee. The Chapter endeavors to provide the participants with resources for scientific and technical information and educational opportunities. It facilitates meetings and exchange of information with industry representatives from large and small companies, biotech manufacturers, medical device manufacturers, equipment vendors, Ministry of Health officials, academics and consultants.